Access
To read this story in full you will need to login or make a payment (see right).
Opinion
Nature 412, 361 (26 July 2001) | doi:10.1038/35086710
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Faculty Position in Chromosome and Cell Cycle Research
- OMRF
- Oklahoma City, OK 73104, United States
PhD or Postdoctoral Fellow: DFT Calculations in Materials Science
- KAUST (King Abdullah University of Science and Technology)
- Saudi Arabia
Back from the brink
Abstract
The government's threat to suspend clinical trials at America's largest medical school highlights an impasse over funding.
Biomedical researchers in the United States were genuinely stunned last week to learn that the federal government was suspending the clinical research programmes at Johns Hopkins University (JHU) in Baltimore, the largest academic medical centre in the country, and one of the most revered.The suspension announced by the fledgling Office for Human Research Protections (OHRP) was condemned in unusually forthright terms by JHU researchers and administrators, who clearly felt that the government had overreached itself.
To read this story in full you will need to login or make a payment (see right).
